Magnetization transfer ratio as a predictor of malignancy in breast lesions: Preliminary results

Magnetic Resonance in Medicine

Volumn 59, Issue 5, 2008, Pages 1030-1034

  Bonini, Ruth Helena Morais ^a   Zeotti, Denise ^a   Saraiva, Luciano Albuquerque Lima ^a   Trad, Clovis Simao ^a   Sarmento Filho, Joaquim Moraes ^a   Carrara, Helio Humberto Angotti ^a   De Andrade, Jurandyr Moreira ^a   Santos, Antonio Carlos ^a   Muglia, Valdair Francisco ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Breast cancer; Magnetization transfer; MRI

Indexed keywords

DIAGNOSIS; DISEASES; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MAGNETIZATION;

BREAST CANCER; FIBROGLANDULAR TISSUE; HIGH-RISK PATIENTS; MAGNETIZATION TRANSFER; MAGNETIZATION TRANSFER RATIO; MALIGNANT LESION; NEUROLOGICAL DISEASE; STATISTICALLY SIGNIFICANT DIFFERENCE;

MEDICAL IMAGING;

ADULT; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; MUSCLE TISSUE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE;

EID: 42549135001     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21555     Document Type: Article

References (34)

1. 1 Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001 ; 220: 13–30.
2. 2 Schnall MD, Blume J, Bluemke DA, DeAngelis GA, DeBruhl N, Harms S, Heywang‐Kobrunner SH, Hylton N, Kuhl CK, Pisano ED, Causer P, Schnitt SJ, Thickman D, Stelling CB, Weatherall PT, Lehman C, Gatsonis CA. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 2006 ; 238: 42–53.
3. 3 Morris EA, Liberman L, Ballon DJ, Robson M, Abramson AF, Heerdt A, Dershaw DD. MRI of occult breast carcinoma in a high‐risk population. AJR Am J Roentgenol 2003 ; 181: 619–626.
4. 4 Brown SL, Middleton MS, Berg WA, Soo MS, Pennello G. Prevalence of rupture of silicone gel breast implants revealed on MR imaging in a population of women in Birmingham, Alabama. AJR Am J Roentgenol 2000 ; 175: 1057–1064.
5. 5 Buchanan CL, Morris EA, Dorn PL, Borgen PI, Van Zee KJ. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg Oncol 2005 ; 12: 1045–1053.
6. 6 Yeh E, Slanetz P, Kopans DB, Rafferty E, Georgian‐Smith D, Moy L, Halpern E, Moore R, Kuter I, Taghian A. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 2005 ; 184: 868–877.
7. 7 Kinkel K, Helbich TH, Esserman LJ, Barclay J, Schwerin EH, Sickles EA, Hylton NM. Dynamic high‐spatial‐resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability. AJR Am J Roentgenol 2000 ; 175: 35–43.
8. 8 Tozaki M, Igarashi T, Matsushima S, Fukuda K. High‐spatial‐resolution MR imaging of focal breast masses: interpretation model based on kinetic and morphological parameters. Radiat Med 2005 ; 23: 43–50.
9. 9 Morris EA. Review of breast MRI: indications and limitations. Semin Roentgenol 2001 ; 36: 226–237.
10. 10 Szabo BK, Aspelin P, Wiberg MK, Bone B. Dynamic MR imaging of the breast. Analysis of kinetic and morphologic diagnostic criteria. Acta Radiol 2003 ; 44: 379–386.
11. 11 Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast‐enhanced MR imaging on the therapeutic approach. Radiology 1999 ; 213: 881–888.
12. 12 Nunes LW, Schnall MD, Siegelman ES, Langlotz CP, Orel SG, Sullivan D, Muenz LA, Reynolds CA, Torosian MH. Diagnostic performance characteristics of architectural features revealed by high spatial‐resolution MR imaging of the breast. AJR Am J Roentgenol 1997 ; 169: 409–415.
13. 13 Heywang SH, Wolf A, Pruss E, Hilbertz T, Eiermann W, Permanetter W. MR imaging of the breast with Gd‐DTPA: use and limitations. Radiology 1989 ; 171: 95–103.
14. 14 Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, Schild HH. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999 ; 211: 101–110.
15. 15 Schnall MD, Rosten S, Englander S, Orel SG, Nunes LW. A combined architectural and kinetic interpretation model for breast MR images. Acad Radiol 2001 ; 8: 591–597.
16. 16 Katz‐Brull R, Lavin PT, Lenkinski RE. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 2002 ; 94: 1197–1203.
17. 17 Rumboldt Z, Marotti M. Magnetization transfer, HASTE, and FLAIR imaging. Magn Reson Imaging Clin N Am 2003 ; 11: 471–492.
18. 18 Santos AC, Narayanan S, de Stefano N, Tartaglia MC, Francis SJ, Arnaoutelis R, Caramanos Z, Antel JP, Pike GB, Arnold DL. Magnetization transfer can predict clinical evolution in patients with multiple sclerosis. J Neurol 2002 ; 249: 662–668.
19. 19 Horsfield MA. Magnetization transfer imaging in multiple sclerosis. J Neuroimaging 2005 ; 15 (4 Suppl): 58S–67S.
20. 20 Callicott C, Thomas JM, Goode AW. The magnetization transfer characteristics of human breast tissues: an in vitro NMR study. Phys Med Biol 1999 ; 44: 1147–1154.
21. 21 Santyr GE, Kelcz F, Schneider E. Pulsed magnetization transfer contrast for MR imaging with application to breast. J Magn Reson Imaging 1996 ; 6: 203–212.
22. 22 Dousset V, Grossman RI, Ramer KN, Schnall MD, Young LH, Gonzalez‐Scarano F, Lavi E, Cohen JA. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992 ; 182: 483–491.
23. 23 Heywang‐Kobrunner SH, Schlegel A, Beck R, Wendt T, Kellner W, Lommatzsch B, Untch M, Nathrath WB. Contrast‐enhanced MRI of the breast after limited surgery and radiation therapy. J Comput Assist Tomogr 1993 ; 17: 891–900.
24. 24 Furman‐Haran E, Schechtman E, Kelcz F, Kirshenbaum K, Degani H. Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions. Cancer 2005 ; 104: 708–718.
25. 25 Stelling CB, Powell DE, Mattingly SS. Fibroadenomas: histopathologic and MR imaging features. Radiology 1987 ; 162: 399–407.
26. 26 Forsén S, Hoffman RA. Study of moderately rapid chemical exchange reactions by means of nuclear magnetic double resonance. J Chem Phys 1963 ; 39: 2892–2901.
27. 27 Edzes HT, Samulski ET. Cross relaxation and spin diffusion in the proton NMR or hydrated collagen. Nature 1977 ; 265: 521–523.
28. 28 Wolff SD, Balaban RS. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med 1989 ; 10: 135–144.
29. 29 Narayanan S, Francis SJ, Sled JG, Santos AC, Antel S, Levesque I, Brass S, Lapierre Y, Sappey‐Marinier D, Pike GB Arnold DL. Axonal injury in the cerebral normal‐appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal‐appearing white matter. Neuroimage 2006 ; 29: 637–642.
30. 30 Christensen L. The distribution of fibronectin, laminin and tetranectin in human breast cancer with special attention to the extracellular matrix. APMIS Suppl 1992 ; 26: 1–39.
31. 31 Deng SS, Xing TY, Zhou HY, Xiong RH, Lu YG, Wen B, Liu SQ, Yang HJ. Comparative proteome analysis of breast cancer and adjacent normal breast tissues in human. Genom Proteom Bioinform 2006 ; 4: 165–172.
32. 32 Ioachim E, Charchanti A, Briasoulis E, Karavasilis V, Tsanou H, Arvanitis DL, Agnantis NJ, Pavlidis N. Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. Eur J Cancer 2002 ; 38: 2362–2370.
33. 33 Somiari RI, Sullivan A, Russell S, Somiari S, Hu H, Jordan R, George A, Katenhusen R, Buchowiecka A, Arciero C, Brzeski H, Hooke J, Shriver C. High‐throughput proteomic analysis of human infiltrating ductal carcinoma of the breast. Proteomics 2003 ; 3: 1863–1873.
34. 34 Tofts PS, Steens SC, Cercignani M, Admiraal‐Behlouf F, Hofman PA, van Osch MJ, Teeuwisse WM, Tozer DJ, van Waesberghe JH, Yeung R, Barker GJ, van Buchem MA. Sources of variation in multi‐centre brain MTR histogram studies: body‐coil transmission eliminates inter‐centre differences. MAGMA 2006 ; 19: 209–222.